Naltrexone 5mg/5ml oral suspension
BNF presentation 0410030E0AAATAT within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0410030E0AAATAT
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
59
NHS spend (£)
£4,360.70
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 10 |
| December 2024 | 2 |
| November 2024 | 6 |
| October 2024 | 8 |
| July 2024 | 3 |
| May 2024 | 2 |
| July 2021 | 4 |
| December 2020 | 15 |
| November 2020 | 9 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 5 | No data available |
|
Lakeside Healthcare Stamford
ODS C83007
|
4 | 71E - LINCOLNSHIRE ICB |
| Unknown pharmacy | 4 | No data available |
|
Yealm Medical Centre
ODS L83081
|
4 | 15N - DEVON ICB |
| Unknown pharmacy | 3 | No data available |
|
Wealden Ridge Medical Partnership
ODS G81088
|
3 | 97R - SUSSEX ICB |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 2 | No data available |